Heart Failure

This heart failure channel offers news and new technology to treat heart failure. This includes for new innovations to treat congestive heart failure (CHF). The channel includes news on HFpEF and HFrEF. Heart failure occurs when the heart is no longer able to pump as much blood as the body requires. This can lead to enlargement of the heart because the muscle works harder to supply blood, but the pumping is ineffective. This may be due to defects in the myocardium, such as an infarct, or due to structural issues such as severe valve regurgitation. The disease is divided into four New York Heart Association (NYHA) classes. Stage IV heart failure is when the heart is completely failing and requires a heart transplant  or a left ventricular assist device (LVAD).

Estimates of excess deaths, defined as the number of persons who have died from all causes, above the expected number of deaths for a given place and time, can provide a comprehensive account of mortality likely related to the COVID-19 pandemic, including deaths that are both directly and indirectly associated with COVID-19
News | Coronavirus (COVID-19)
CDC Update on Excess Deaths Associated with the COVID-19 Pandemic

May 13, 2021 — Estimates of excess deaths, defined as the number of persons who have died from all causes, above the ...

Home May 13, 2021
Home
The BioCardia cardiac stem cell CardiAMP trial is a Phase III study looking at the efficacy of using stem cells to improve heart function in heart failure patients. It is the first trial for this technology to reach Phase III trial.
Feature | Stem Cell Therapies | By Simon H. Stertzer, M.D.
Is Cardiac Cell Therapy Worth Another Look?

Heart failure remains an unheralded global pandemic, costing society billions of dollars each year.[1,2] Projections ...

Home May 11, 2021
Home
The American Institute of Ultrasound in Medicine (AIUM) and the American Society of Echocardiography (ASE) have joined the International Contrast Ultrasound Society (ICUS) in recognizing the relatively low risk and important clinical benefits of ultrasound contrast agents (UCAs), which are used routinely around the world to help detect heart disease, stratify the risk of heart attack or stroke, identify and characterize tumors throughout the abdomen, and monitor the effectiveness of cancer therapies in adul
News | Contrast Media
Medical Societies Support Safety and Benefits of Ultrasound Contrast Agents

May 11, 2021 — The American Institute of Ultrasound in Medicine (AIUM) and the American Society of Echocardiography (ASE ...

Home May 11, 2021
Home
Patients hospitalized with COVID-19 may be at risk of developing heart failure even if they do not have a previous history of heart disease or cardiovascular risk factors, a new Mount Sinai study shows. 
News | Heart Failure
Patients Hospitalized With COVID-19 Have a Small Risk of Heart Failure

May 11, 2021 — Patients hospitalized with COVID-19 may be at risk of developing heart failure even if they do not have a ...

Home May 11, 2021
Home
Racism and heart disease. This study looks at heart failure patients and the impact of socioeconomic disparities associate with epigenetics. The study looks to overcome preconcieved ideas about race in cardiac studies by looking at underlaying causes for the disease. Image courtesy of the American Journal of Physiology
News | Heart Failure
Socioeconomic Disparities Associate With Epigenetics and Heart Failure Outcomes

April 26, 2021 – Cardiovascular diseases are the leading cause of death in the United States. Heart failure disproportio ...

Home April 26, 2021
Home
COVID-19 disrupted all aspects of science and medicine and unmasked striking disparities and opportunities for transformation. Coronavirus impact this past year is expected to result in a massive rise in new cases of chronic health conditions, including cardiolvascular disease and heart failure.
News | Coronavirus (COVID-19)
Tsunami of Chronic Health Conditions Expected Due to COVID-19 Disruption of Healthcare

April 6, 2021 — A tsunami of chronic health conditions as a result of the COVID-19 (SARS-CoV-2) pandemic, especially car ...

Home April 07, 2021
Home
The Transmedics Organ Care System (OCS) Heart, or “Heart in a Box,” enables transplant surgeons to travel to much farther destinations to procure transplant hearts by acting as a miniature intensive care unit that keeps the heart alive.
News | Cardiovascular Surgery
Heart in a Box Technology Expands Heart Transplant Window

April 5, 2021 — Smidt Heart Institute transplant surgeons Dominic Emerson, M.D., and Pedro Catarino, M.D. know how to be ...

Home April 05, 2021
Home
PA pressure-guided heart failure management is fast becoming the standard of care in NYHA Class III patients. The Cordella Pulmonary Artery Pressure Sensor enables clinicians to remotely monitor and proactively adjust therapy and medications remotely without the need for office visits.
News | Heart Failure
100th Patient Implanted With Cordella Pulmonary Artery Pressure Sensor For Proactive, Remote Heart Failure Management

March 24, 2021 — Endotronix Inc., a digital health and medical technology company working on advancements in treating of ...

Home March 24, 2021
Home
Videos | Ventricular Assist Devices (VAD)
VIDEO: New LVAD Designed to Prevent Hemolysis and Clots

Surgeons at Penn State Heart and Vascular Institute were the second group in the nation to implant a newly-designed ...

Home March 22, 2021
Home
A study from Washington University School of Medicine in St. Louis provides evidence that the coronavirus can invade and replicate inside heart muscle cells, causing cell death and interfering with heart muscle contraction. The image of engineered heart tissue shows human heart muscle cells (red) infected with COVID-19 (SARS-CoV-2) (green). Image by Lina Greenberg.
Feature | Coronavirus (COVID-19)
COVID-19 Can Kill Heart Cells and Interfere With Contraction

March 12, 2021 — Since early in the pandemic, COVID-19 has been associated with heart problems, including reduced ...

Home March 12, 2021
Home
AMERICAN COLLEGE OF CARDIOLOGY (ACC) Late-breaking clinical trial study presentations at ACC.21. @ACC21 @ACC2021
Feature | ACC | Dave Fornell, Editor
ACC 2021 Late Breaking Cardiology Study Results

The latest cardiology practice-changing scientific breakthrough, late-breaking study presentations have been announced ...

Home May 18, 2021
Home
News | Cardiac Resynchronization Therapy Devices (CRT)
CRT May Benefit More Heart Failure Patients in New Analysis of REVERSE Trial

March 3, 2021 — Medtronic announced new results from the landmark REVERSE trial, evaluating outcomes of cardiac ...

Home March 03, 2021
Home
Impulse Dynamics Optimizer Smart device is an implantable device that helps optimize cardiac pumping action in heart failure patients.
News | Heart Failure
European Union Allows MRI Scans of Heart Failure Patients With Impulse Dynamics Implanted Optimizer Smart Devices

March 3, 2021 — Impulse Dynamics recently announced that DEKRA Certification B.V., a global regulatory organization ...

Home March 03, 2021
Home
LVAD patient Richard Huggins with the external control and power unit for his new EvaHeart2 left ventricular assist device at Penn State Health's Hershey Medical Center. 
News | Heart Failure
Hershey Medical Center Second in the Nation to Implant EvaHeart2 LVAD

March 2, 2021 — Penn State Health Milton S. Hershey Medical Center became the second hospital in the nation to implant a ...

Home March 02, 2021
Home
Medtronic Recalls HVAD Pump Implant Kits After 2 Deaths and 19 Serious Injuries
News | Ventricular Assist Devices (VAD)
Medtronic Recalls HVAD Pump Implant Kits After 2 Deaths and 19 Serious Injuries

March 1, 2021 — Medtronic is recalling the HeartWare Ventricular Assist Device (HVAD) Pump Implant Kit because the left ...

Home March 01, 2021
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now